Results 141 to 150 of about 5,218,116 (247)
New Zealand [cartographic material] [PDF]
Map of New Zealand showing administrative districts highlighted in different colours; Plate [6] from: Whitehead's Atlas of Australasia. Melbourne : Published by E. Whitehead & Co., 1870.; Also available in an electronic version via the internet at: http:
Whitehead & Co.
core
Karte der Gilbert oder Kingsmill In. [cartographic material] : nach den neusten Quellen u. privaten Notizen / [PDF]
Plate 5 from: [Maps of Oceania by L.Friederichsen & Co., probably published in Mitteilungen der Geographischen Gesellschaft in Hamburg, 1879]. Hamburg : L. Friederichsen & Co., 1879.; Map of Gilbert Islands (Kiribati).
L. Friederichsen & Co.
core
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
Karte der Ansiedelungen am Hafen von Apia, Insel Upolo [cartographic material] / [PDF]
Plate 3 from: [Maps of Oceania by L.Friederichsen & Co., probably published in Mitteilungen der Geographischen Gesellschaft in Hamburg, 1879]. Hamburg : L. Friederichsen & Co., 1879.; Map of Apia, Samoa.
L. Friederichsen & Co.
core
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht +53 more
wiley +1 more source
A guide for comparing microbial co‐occurrence networks
Chi Liu +5 more
doaj +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
ABSTRACT Objective Intravenous thrombolysis (IVT) before thrombectomy for ischemic stroke may alter clot structure and procedural performance. We investigated how IVT relates to thrombectomy metrics across stroke etiologies. Methods We performed a time‐to‐event analysis of consecutive patients with anterior circulation large vessel occlusion (acLVO ...
Annahita Sedghi +8 more
wiley +1 more source
SPG4 and Dementia: Expanding the Clinical Spectrum
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza +19 more
wiley +1 more source
ABSTRACT Objective Stereoelectroencephalography‐guided radiofrequency thermocoagulation (SEEG‐RFTC) has emerged as a safe and effective minimally invasive treatment for children with drug‐resistant focal epilepsy. Although evidence from real‐world studies remains limited, numerous pediatric cases have demonstrated promising outcomes. This retrospective
Weitao Chen +7 more
wiley +1 more source

